Celularity Inc.

CELUW

NASDAQ

Healthcare

Biotechnology

Florham Park, NJ, US120 employeescelularity.com

$0.01

+0.00(1.32%)

Mkt Cap $185.2K

$0.01

$0.08

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Product (63%), License Royalty And Other (23.3%), Service (13.7%).

8-K

Celularity Inc. entered into an Asset Purchase and Exclusive License Agreement with NexGel, Inc. on March 6, 2026. The Company issued a press release on March 10, 2026 announcing the transaction, with the agreement filed as Exhibit 10.1.

$185.2K

Market Cap

$5.4B

Revenue

-$10.7B

Net Income

Employees120

Fundamentals

How The Business Makes Money

Revenue by Segment

Product63%($48M)

License Royalty And Other23.3%($18M)

Service13.7%($11M)

Activity

What Changed Recently

Management Change

Mar 4, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers . On February 2

Management Change

Jan 20, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers . On January 16

Material Agreement

Mar 9, 2026

. Entry into a Material Definitive Agreement. On March 6, 2026, Celularity Inc., a Delaware corporation (the “Company”), entered into an Asset Purchase and Excl

Company Profile

CIK0001752828

ISINUS1511901134

CUSIP151190113

Phone908 768 2170

Address170 Park Avenue, Florham Park, NJ, 07932, US

SEC EDGAR